The rat as a model for cardiovascular disease

Drug Discovery Today: Disease Models

Volumn 5, Issue 3, 2008, Pages 173-178

  Dillmann, W H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN HEAVY CHAIN ALPHA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TISSUE KALLIKREIN;

CARDIOTOXICITY; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE MODEL; EX VIVO STUDY; GENE DELETION; GENE EXPRESSION; GENE MAPPING; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE HYPERTROPHY; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; NONHUMAN; POLYMORPHIC LOCUS; QUANTITATIVE TRAIT LOCUS; RAT STRAIN; REVIEW; TRANSGENIC RAT; VASCULAR DISEASE; WILD TYPE;

EID: 67651222435     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2009.03.006     Document Type: Review

References (42)

1. Canby T.Y., and Stanfield J.L. The rat - lapdog of the devil. Natl. Geogr. 15 (1977) 60-87
2. Gill III T.J. The rat in biomedical research. Physiologist 28 (1985) 9-17
3. Crampe H. Zuchtversuche mit zahmen Wanderratten. I. Resulte der Zucht in Verwandtschaft Vol. 12 (1883), Landwirtsch, Jahrb pp. 389-449
4. Lindsey J.R., et al. In: Suckow M.A., Weisbroth S.H., and Franklin C.L. (Eds). The Laboratory Rat. 2nd edn (2006), Elsevier, Burlington, MA
5. Anderson P.G., et al. In: Suckow M.A., Weisbroth S.H., and Franklin C.L. (Eds). The Laboratory Rat. 2nd edn (2006), Elsevier, Burlington, MA
6. Lee N.H. Physiogenomic strategies and resources to associate genes with rat models of heart, lung and blood disorders. Exp. Physiol. 92 (2007) 992-1002
7. Hubner N., et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat. Genet. 37 (2005) 243-253
8. Okamoto K. Spontaneous Hypertension: Its Pathogenesis and Complications (1972), Spring, Berlin
9. Gibbs R.A., et al. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428 (2004) 493-521
10. Li C., et al. Derivation and transcriptional profiling analysis of pluripotent stem cell lines from rat blastocysts. Cell Res. 19 (2009) 173-186
11. Hulman S., et al. Insulin resistance in the conscious spontaneously hypertensive rat: euglycemic hyperinsulinemic clamp study. Metabolism 42 (1993) 14-18
12. Aitman T.J., et al. Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat. Genet. 16 (1997) 197-201
13. Pinto Y.M., et al. Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc. Res. 39 (1998) 77-88
14. Meneely G.R., and Ball C.O. Experimental epidemiology of chronic sodium chloride toxicity and the protective effect of potassium chloride. Am. J. Med. 25 (1958) 713-725
15. Rapp J.P. Dahl salt susceptible and salt resistant rats. Hypertension 4 (1982) 753-763
16. Heyen J.R., et al. Structural, functional, and molecular characterization of the SHHF model of heart failure. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H1775-H1784
17. Tirabassi R.S., et al. The BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitus. ILAR J. 45 (2004) 292-302
18. Moran T.H. Unraveling the obesity of OLETF rats. Physiol. Behav. 94 (2008) 71-78
19. Mullins J.J., et al. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344 (1990) 541-544
20. Pol C.J., et al. Cardiomyocyte-specific inactivation of thyroid hormone in pathologic ventricular hypertrophy: an adaptative response or part of the problem?. Heart Fail. Rev. (2008) (Epub ahead of print)
21. Shiojima I., et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 115 (2005) 2108-2118
22. Plotkin B.J., and Paulson D. Zucker rat (fa/fa), a model for the study of immune function in type-II diabetes mellitus: effect of exercise and caloric restriction on the phagocytic activity of macrophages. Lab. Anim. Sci. 46 (1996) 682-684
23. Prinzen F.W., and Bassingthwaighte J.B. Blood flow distributions by microsphere deposition methods. Cardiovasc. Res. 45 (2000) 13-21
24. Raher M.J., et al. In vivo characterization of murine myocardial perfusion with myocardial contrast echocardiography: validation and application in nitric oxide synthase 3 deficient mice. Circulation 116 (2007) 1250-1257
25. Neely J.R., et al. Effect of pressure development on oxygen consumption by isolated rat heart. Am. J. Physiol. 212 (1967) 804-814
26. Curtis M.J. Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischemia-induced ventricular fibrillation. Cardiovasc. Res. 39 (1998) 194-215
27. Taegtmeyer H., et al. Utilization of energy-providing substrates in the isolated working rat heart. Biochem. J. 186 (1980) 701-711
28. Strobeck J.E., et al. Load and time considerations in the force-length relation of cardiac muscle. Fed. Proc. 39 (1980) 175-182
29. 2+ transients. Circulation 96 (1997) 400-403
30. Greenberg M.J., et al. Regulatory light chain mutations associated with cardiomyopathy affect myosin mechanics and kinetics. J. Mol. Cell Cardiol. 46 (2009) 108-115
31. Okamomoto A.K. Development of a strain of spontaneously hypertensive rat. Jap. Circ. J. 27 (1963) 282-293
32. Nagura J., et al. Effect of chronic treatment with ME3221 on blood pressure and mortality in aged stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. Suppl. 22 (1995) S363-S365
33. Dahl L.K., et al. Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 194 (1962) 480-482
34. Deng Y., and Rapp J.P. Cosegregation of blood pressure with angiotensin converting enzyme and atrial natriuretic peptide receptor genes using Dahl salt-sensitive rats. Nat. Genet. 1 (1992) 267-272
35. Russell J.C., and Amy R.M. Myocardial and vascular lesions in the LA/N-corpulent rat. Can. J. Physiol. Pharmacol. 64 (1986) 1272-1280
36. Bader M., et al. Transgenic animals in cardiovascular disease research. Exp. Physiol. 85 (2000) 713-731
37. Silva Jr. J.A., et al. Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene. FASEB J. 14 (2000) 1858-1860
38. Hocher B., et al. Characterization of the renal phenotype of transgenic rats expressing the human endothelin-2 gene. Hypertension 28 (1996) 196-201
39. 2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats. Cardiovasc. Res. 67 (2005) 636-646
40. 2+ handling in normal and diabetic rat hearts. FASEB J. 16 (2002) 1657-1659
41. Herrera V.L., and Ruiz-Opazo N. Genetic studies in rat models: insights into cardiovascular disease. Curr. Opin. Lipidol. 16 (2005) 179-191
42. Grundy S.M., et al. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438